semaglutide medical weight loss aurora Minnesota doctor says FDA weight-loss drug cutoff is 'devastating' for patients A Mayo Clinic study found

Stability considerations are discussed in GLP-1 peptide stability analytical methods

Evidence in Cocaine Use Disorder One clinical study found no differences in self-reported euphoria, craving, or cocaine infusions in individuals with cocaine use disorder treated with exenatide compared with placebo

Small DM, Coombes JS, Bennett N, Johnson DW, Gobe GC (2012) Oxidative stress, anti-oxidant therapies and chronic kidney disease

FDA Approves Wegovy to Reduce Heart Disease and Stroke Risk in People With Obesity The FDA has now approved Wegovy to reduce cardiovascular risk in people with obesity, in a label expansion based on results from Novo Nordisks SELECT trial

Reconstitution for topical use Most peptides arrive as lyophilized powder that requires reconstitution